Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept

References

• FerrisFLIIIFineSLHymanLAge-related macular degeneration and blindness due to neovascular maculopathyArch Ophthalmol198410211164016426208888
   PubMed Web of Science ®Google Scholar
• Macular Photocoagulation Study GroupArgon Laser photocoagulation for neovascular maculopathyArch Ophthalmol19861046947012423061
   PubMed Web of Science ®Google Scholar
• Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study GroupVerteporfin Therapy of Subfoveal Choroidal Neovascularization in Patients with Age-Related Macular DegenerationArch Ophthalmol20021201443145412427056
   PubMedGoogle Scholar
• RosenfeldPJBrownDMHeierJSRanibizumab for age-related macular degenerationN Engl J Med20063551419143117021318
   PubMed Web of Science ®Google Scholar
• BrownDMKaiserPKMichelsMRanibizumab versus verteporfin for neovascular age-related macular degenerationN Engl J Med20063341432144417021319
   PubMed Web of Science ®Google Scholar
• MartinDFMaguireMGYingG-SRanibizumab and bevacizumab for neovascular age-related macular degenerationN Engl J Med2011364201897190821526923
   PubMed Web of Science ®Google Scholar
• http://investor.regeneron.com/releasedetail.cfm?ReleaseID=532099Accessed March 19, 2012
   Google Scholar
• BlochSBLarsenMMunchICIncidence of legal blindness from age-related macular degeneration in Denmark: year 2000–2010Am J Ophthalmol20121532209213e222264944
   PubMed Web of Science ®Google Scholar
• Macular Photocoagulation Study GroupArgon laser photocoagulation for neovascular maculopathy: five-year results from randomized clinical trialsArch Ophthalmol1991109110911141714270
   PubMed Web of Science ®Google Scholar
• Macular Photocoagulation Study GroupLaser photocoagulation for juxtafoveal choroidal neovascularization: five-year results from randomized clinical trialsArch Ophthalmol19941125005097512336
   PubMedGoogle Scholar
• FreundKBYannuzziLASorensonJAAge-related macular degeneration and choroidal neovascularizationAm J Ophthalmol19931157867917685148
   PubMed Web of Science ®Google Scholar
• BermigJTyllaHJochmannCAngiographic findings in patients with exudative age-related macular degenerationGraefes Arch Clin Exp Ophthalmol200224016917511935273
   PubMed Web of Science ®Google Scholar
• GassJDPathogenesis of disciform detachment of the neuroepitheliumAm J Ophthalmol196763Suppl 1S1S139
   Google Scholar
• GreenWREngerCAge-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman LectureOphthalmology1993100151915357692366
   PubMed Web of Science ®Google Scholar
• GreenWRHistopathology of age-related macular degenerationMol Vis19995273610562651
   PubMed Web of Science ®Google Scholar
• ArjamaaONikinmaaMSalminenAKaarnirantaKRegulatory role of HIF-1α in the pathogenesis of age-related macular degeneration (AMD)Ageing Res Rev2009834935819589398
   PubMed Web of Science ®Google Scholar
• DunaiefJLDentchevTYingGMilamAHThe role of apoptosis in age-related macular degenerationArch Ophthalmol20021201435144212427055
   PubMedGoogle Scholar
• StefanssonEGeirsdóttirASigurdssonHMetabolic physiology in age related macular degenerationProg Retin Eye Res201130728020951826
   PubMed Web of Science ®Google Scholar
• BresslerNMBresslerSBFineSLAge-related macular degenerationSurv Ophthalmol1988323754132457955
   PubMed Web of Science ®Google Scholar
• LoaneENolanJMO’DonovanOTransport and retinal capture of lutein and zeaxanthin with reference to age-related macular degenerationSurv Ophthalmol200853687118191658
   PubMed Web of Science ®Google Scholar
• TserentsoodolNSzteinJCamposMUptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated processMol Vis2006121306131817110914
   PubMed Web of Science ®Google Scholar
• BarnstableTombran-TinkJNeuroprotective and antiangiogenic actions of PEDF in the eye: molecular targets and therapeutic potentialProg Retin Eye Res20042356157715302351
   PubMed Web of Science ®Google Scholar
• KimPKHaileyDWMullenRTLippincott-SchwartzJUbiquitin signals autophagic degradation of cytosolic proteins and peroxisomesProc Nat Acad Sci USA2008105205672057419074260
   PubMed Web of Science ®Google Scholar
• StraussOThe retinal pigment epithelium in visual functionPhysiol Rev20058584588115987797
   PubMed Web of Science ®Google Scholar
• AlgverePVSeregardSAge-related maculopathy: pathogenetic features and new treatment modalitiesActa Ophthalmol Scand20028013614311952478
   PubMedGoogle Scholar
• DeloriFCGogerDGDoreyCKAge-related accumulation and spatial distribution of lipofuscin in RPE of normal subjectsInvest Ophthalmol Vis Sci2001421855186611431454
   PubMed Web of Science ®Google Scholar
• SparrowJRCaiBFishkinNA2E, a fluorophore of RPE lipofuscin: can it cause RPE degeneration?Adv Exp Med Biol200353320521115180266
   PubMed Web of Science ®Google Scholar
• WarburtonSSouthwickKHardmanRMExamining the proteins of functional retinal lipofuscin using proteomic analysis as a guide for understanding its originMol Vis2005111122113416379024
   PubMed Web of Science ®Google Scholar
• BindewaldABirdACDandekarSSClassification of fundus autofluorescence patterns in early age-related macular diseaseInvest Ophthalmol Vis Sci2005463309331416123434
   PubMed Web of Science ®Google Scholar
• HolzFGBindewald-WittichAFleckensteinMFAM-Study GroupProgression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degenerationAm J Ophthalmol200714346347217239336
   PubMed Web of Science ®Google Scholar
• RubertiJWCurcioCAMillicanCLQuick-freeze/deep-etch visualization of age-related lipid accumulation in Bruch’s membraneInvest Ophthalmol Vis Sci2003441753175912657618
   PubMed Web of Science ®Google Scholar
• HuangJDPresleyJBChimentoMFAge-related changes in human macular Bruch’s membrane as seen by quick-freeze/deep-etchExp Eye Res20078520221817586493
   PubMed Web of Science ®Google Scholar
• HolzFGSheraidahGPauleikhoffDAnalysis of lipid deposits extracted from human macular and peripheral Bruch’s membraneArch Ophthalmol19941124024068129668
   PubMed Web of Science ®Google Scholar
• NordgaardCLKarunadharmaPPFengXOlsenTWFerringtonDAMitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degenerationInvest Ophthalmol Vis Sci2008492848285518344451
   PubMed Web of Science ®Google Scholar
• HartlFUMolecular chaperones in cellular protein foldingNature19963815715798637592
   PubMed Web of Science ®Google Scholar
• HartlFUHayer-HartlMMolecular chaperones in the cytosol: from nascent chain to folded proteinScience20022951852185811884745
   PubMed Web of Science ®Google Scholar
• KopitoRRAggresomes, inclusion bodies and protein aggregationTrends Cell Biol20001052453011121744
   PubMed Web of Science ®Google Scholar
• WojcikCRegulation of apoptosis by the ubiquitin and proteosome pathwayJ Cell Mol Med20026254812003667
   PubMed Web of Science ®Google Scholar
• KaarniranataKSalminenAEskelinenEKopitzJHeat shock proteins as gatekeepers of proteolytic pathways – implications for age-related macular degeneration (AMD)Ageing Res Rev2009812813919274853
   PubMed Web of Science ®Google Scholar
• WassellJDaviesSBardsleyWBoultonMThe photoreactivity of the retinal age pigment lipofuscinJ Biol Chem1999274238282383210446145
   PubMed Web of Science ®Google Scholar
• HolzFSchuttFKopitzJInhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscinInvest Ophthalmol Vis Sci19994073774310067978
   PubMed Web of Science ®Google Scholar
• JavittNBJavittJCThe retinal oxysterol pathway: a unifying hypothesis for the cause of age-related macular degenerationCurr Opin Ophthalmol20092015115719390436
   PubMed Web of Science ®Google Scholar
• CrabbJWMiyagiMGuXDrusen proteome analysis: an approach to the etiology of age-related macular degenerationProc Natl Acad Sci USA200299146821468712391305
   PubMed Web of Science ®Google Scholar
• HowesKALiuYDunaiefJLReceptor for advanced glycation end products and age-related macular degenerationInvest Ophthalmol Vis Sci20044537143720
   Web of Science ®Google Scholar
• OskolkovaOVAfonyushkinTLeitnerAATF4-dependent transcription is a key mechanism in VEGF up-regulation by oxidized phospholipids: critical role of oxidized sn-2 residues in activation of unfolded protein responseBlood200811233033918451308
   PubMed Web of Science ®Google Scholar
• ElnerSGPettyHRElnerVMTLR4 mediates human retinal pigment epithelial endotoxin binding and cytokine expressionInvest Ophthalmol Vis Sci2005464627463316303959
   PubMed Web of Science ®Google Scholar
• EbiharaNChenLTokuraTUshioHIwatsuMMurakamiADistinct functions between toll-like receptors 3 and 9 in retinal pigment epithelial cellsOphthalmic Res20073915516317534115
   PubMed Web of Science ®Google Scholar
• KumarMVNagineniCNChinMSHooksJJDetrickBInnate immunity in the retina: toll-like receptor (TLR) signaling in human retinal pigment epithelial cellsJ Neuroimmunol200415371515265658
   PubMed Web of Science ®Google Scholar
• KindzelskiiALElnerVMElnerSGYangDHughesBAPettyHRToll-like receptor 4 (TLR4) of retinal pigment epithelial cells participates in trans-membrane signaling in response to photoreceptor outer segmentsJ Gen Physiol200412413914915277575
   PubMed Web of Science ®Google Scholar
• PaimelaTRyhänenTMannermaaEThe effect of 17β-estradiol on IL-6 secretion and NF-kB DNA-binding activity in human retinal pigment epithelial cellsImmunol Lett200711013914417532054
   PubMed Web of Science ®Google Scholar
• HoltkampGMKijlstraAPeekRde VosAFRetinal pigment epithelium- immune system interactions: cytokine production and cytokine-induced changesProg Retin Eye Res200120294811070367
   PubMed Web of Science ®Google Scholar
• YangDElnerSGBianZPro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH in cultured RPE cellsExp Eye Res20078546247217765224
   PubMed Web of Science ®Google Scholar
• SalminenAKauppinenAHyttinenJMTotopainenEKaarnirantaKEndoplasmic reticulum stress in age-related macular degeneration: trigger for neovascularizationMol Med20101653554220683548
   PubMed Web of Science ®Google Scholar
• HagemanGSLuthertPJVictor ChongNHJohnsonLVAndersonDHMullinsRFAn integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch’s membrane interface in aging and age-related macular degenerationProg Retin Eye Res20012070573211587915
   PubMed Web of Science ®Google Scholar
• PenfoldPLProvisJMFurbyJHGatenbyPABillsonFAAutoantibodies to retinal astrocytes associated with age-related macular degenerationGraefes Arch Clin Exp Ophthalmol19902282702742193850
   PubMed Web of Science ®Google Scholar
• GurneDHTsoMOEdwardDPRippsHAntiretinal antibodies in serum of patients with age-related macular degenerationOphthalmology1991986026071905796
   PubMed Web of Science ®Google Scholar
• KillingsworthMCSarksJPSarksSHMacrophages related to Bruch’s membrane in age-related macular degenerationEye199046136212226993
   PubMed Web of Science ®Google Scholar
• OhHTakagiHTakagiCThe potential angiogenic role of macrophages in the formation of choroidal neovascular membranesInvest Ophthalmol Vis Sci1999401891189810440240
   PubMed Web of Science ®Google Scholar
• FrankRNAminRHEliottDBasic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranesAm J Ophthalmol19961223934038794712
   PubMed Web of Science ®Google Scholar
• AminRPuklinJEFrankRNGrowth factor localization in choroidal neovascular membranes of age-related macular degenerationInvest Ophthalmol Vis Sci199435317831887519180
   PubMed Web of Science ®Google Scholar
• SoubraneGCohenSYDelayreTBasic fibroblast growth factor experimentally induced choroidal angiogenesis in the minipigCurr Eye Res1994131831957514965
   PubMed Web of Science ®Google Scholar
• KimuraHSakamotoTHintonDRA new model of subretinal neovascularization in the rabbitInvest Ophthalmol Vis Sci199536211021197657549
   PubMed Web of Science ®Google Scholar
• TobeTOrtegaSLunaJDTargeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine modelAm J Pathol1998153164116469811357
   PubMed Web of Science ®Google Scholar
• BouckNPEDF anti-angiogenic guardian of ocular functionTrends Mol Med2002833033412114112
   PubMed Web of Science ®Google Scholar
• DuhEJYangHSSuzumaIPigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growthInvest Ophthalmol Vis Sci20024382182911867604
   PubMed Web of Science ®Google Scholar
• MoriKGehlbachPAndoARegression of ocular neovascularization in response to increased expression of pigment epithelium-derived factorInvest Ophthalmol Vis Sci2002432428243412091447
   PubMed Web of Science ®Google Scholar
• DawsonDWVolpertOVGillisPPigment epithelium-derived factor: a potent inhibitor of angiogenesisScience199928524524810398599
   PubMed Web of Science ®Google Scholar
• OgataNNishikawaMNishimuraTInverse levels of pigment epithelium-derived factor and vascular endothelial growth factor in the vitreous of eyes with rhegmatogenous retinal detachment and proliferative vitreoretinopathyAm J Ophthalmol200213385185212036691
   PubMed Web of Science ®Google Scholar
• Ohno-MatsuiKMoritaITombran-TinkJNovel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDFJ Cell Physiol200118932333311748590
   PubMed Web of Science ®Google Scholar
• RennoRZYoussriAIMichaudNExpression of pigment epithelium-derived factor in experimental choroidal neovascularizationInvest Ophthalmol Vis Sci20024315731580
   Google Scholar
• YancopoulosGDDavisSGaleNWvascular-specific growth factors and blood vessel formationNature200040724224811001067
   PubMed Web of Science ®Google Scholar
• ThurstonGRudgeJSIoffeEAngiopoietin-1 protects the adult vasculature against plasma leakageNat Med2000646046310742156
   PubMed Web of Science ®Google Scholar
• OhHTakagiHSuzumaKHypoxia and vascular endothelial growth factor selectively upregulate angiopoietin-2 in bovine microvascular endothelial cellsJ Biol Chem1999274157321573910336473
   PubMed Web of Science ®Google Scholar
• GreenWREngerCAge-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman LectureRetina2005251519153516049370
   PubMedGoogle Scholar
• GreenWRKeySN3rdSenile macular degeneration: a histopathologic study200525180250
   Google Scholar
• AmbatiJAmbatiBKYooSHIanchulevSAdamisAPAge-related macular degeneration: etiology, pathogenesis, and therapeutic strategiesSurv Ophthalmol20034825729312745003
   PubMed Web of Science ®Google Scholar
• GrossniklausHEMartinezJABrownVBImmunohistochemical and histochemical properties of surgically excised subretinal neovascular membranes in age-related macular degenerationAm J Ophthalmol19921144644721415458
   PubMed Web of Science ®Google Scholar
• FrankRNAminRHEliottDBasic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranesAm J Ophthalmol19961223934038794712
   PubMed Web of Science ®Google Scholar
• KvantaAAlgverePVBerglinLSubfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factorInvest Ophthalmol Vis Sci199637192919348759365
   PubMed Web of Science ®Google Scholar
• LopezPFSippyBDLambertHMTrans-differentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranesInvest Ophthalmol Vis Sci1996378558688603870
   PubMed Web of Science ®Google Scholar
• BaffiJByrnesGChanCCChoroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factorInvest Ophthalmol Vis Sci2000413582358911006256
   PubMed Web of Science ®Google Scholar
• SchwesingerCYeeCRohanRMIntrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epitheliumAm J Pathol20011581161117211238064
   PubMed Web of Science ®Google Scholar
• SpilsburyKGarrettKLShenWYOverexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularizationAm J Pathol200015713514410880384
   PubMed Web of Science ®Google Scholar
• WellsJAMurthyRChibberRLevels of vascular endothelial growth factor are elevated in the vitreous of patients with subretinal neovascularizationBr J Ophthalmol1996803633668703891
   PubMed Web of Science ®Google Scholar
• HolekampNMBouckNVolpertOPigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degenerationAm J Ophthalmol200213422022712140029
   PubMed Web of Science ®Google Scholar
• FerraraNVascular endothelial growth factor: basic science and clinical progressEndocr Rev200425458161115294883
   PubMed Web of Science ®Google Scholar
• SengerDRGalliSJDvorakAMPerruzziCAHarveyVSDvorakHFTumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluidScience19832199839856823562
   PubMed Web of Science ®Google Scholar
• FerraraNGerberHLeCouterJThe biology of VEGF and its receptorsNat Med2003966967612778165
   PubMed Web of Science ®Google Scholar
• TermanBIDougher-VermazenMCarrionMEIdentification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochem Biophys Res Commun1992187157915861417831
   PubMed Web of Science ®Google Scholar
• WitmerANVrensenGFVan NoordenCJVascular endothelial growth factors and angiogenesis in eye diseaseProg Retin Eye Res20032212912597922
   PubMed Web of Science ®Google Scholar
• BlaauwgeersHGTHoltkampGMRuttenHPolarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris: evidence for a trophic paracrine relationAm J Pathol199915542142810433935
   PubMed Web of Science ®Google Scholar
• MillerJWAdamisAPAielloLPVascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathyDiabetes Metab Rev19971337509134347
   PubMed Web of Science ®Google Scholar
• KurokiMVoestEEAmanoSReactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivoJ Clin Invest199698495504
   Web of Science ®Google Scholar
• LuMKurokiMAmanoSAdvanced glycation end products increase retinal vascular endothelial growth factor expressionJ Clin Invest1998101121912249502762
   PubMed Web of Science ®Google Scholar
• PapapetropoulosAGarcia-CardeñaGMadriJASessaWCNitric oxide production contributes to the angiogenesis properties of vascular endothelial growth factor in human endothelial cellsJ Clin Invest1997100313131399399960
   PubMed Web of Science ®Google Scholar
• LamoreauxWJFitzgeraldMEReinerAVascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitroMicrovasc Res19985529429473407
   PubMed Web of Science ®Google Scholar
• MottJDWerbZRegulation of matrix biology by matrix metalloproteinasesCurr Opin Cell Biol20041655856415363807
   PubMed Web of Science ®Google Scholar
• KimIRyanARohanRConstitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyesInvest Ophthalmol Vis Sci1999402115212110440268
   PubMed Web of Science ®Google Scholar
• AlonTHemoIItinAVascular endothelial growth factor as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurityNat Med19951102410287489357
   PubMed Web of Science ®Google Scholar
• PapadopoulosNMartinJRuanQBinding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumabAngiogenesis201210.1007/s10456–011–9249–6
   Web of Science ®Google Scholar
• HolashJDavisSPapadopoulosNVEGF-Trap: a VEGF blocker with potent antitumor effectsPNAS200299171139211398
   Web of Science ®Google Scholar
• StewartMWWhat are the half-lives of ranibizumab and aflibercept (VEGF Trap-eye) in human eyes? Calculations with a mathematical modelEye Reports20111e5
   Google Scholar
• StewartMWRosenfeldPJPredicted biological activity of intravitreal VEGF TrapBr J Ophthalmol200892566766818356264
   PubMed Web of Science ®Google Scholar
• DixonJAOliverOlsonJLMandavaNVEGF Trap-eye for the treatment of age-related macular degenerationExpert Opin Investig Drugs2009181015731580
   PubMed Web of Science ®Google Scholar
• CaoJZhaoLLiYA subretinal matrigel rat choroidal neovascularization (CNV) model and inhibition of CNV and associated inflammation and fibrosis by VEGF TrapInvest Ophthalmol Vis Sci201051116009601720538989
   PubMed Web of Science ®Google Scholar
• SaichinYTakahashiKLima e SilvaRVEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrierJ Cell Physiol200319524124812652651
   PubMed Web of Science ®Google Scholar
• CursiefenCChenLBorgesLPVEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitmentJ Clin Invest20041131040105015057311
   PubMed Web of Science ®Google Scholar
• OlivieraHBSakimotoTJavierJADVEGF TrapR1R2 suppresses experimental corneal angiogenesisEur J Ophthalmol201020485419882518
   PubMed Web of Science ®Google Scholar
• NguyenQDShahSMHafizGA phase I trial of an IV-administered vascular endothelial growth factor trap for treatment in patients with choroidal neovascularization due to age-related macular degenerationOphthalmology20061131522153216876249
   PubMed Web of Science ®Google Scholar
• NguyenQDShahSMBrowningDJA phase I study of intravitreal vascular endothelial growth factor trap-eye in patients with neovascular age-related macular degenerationOphthalmology20091162141214819700196
   PubMed Web of Science ®Google Scholar
• BrownDMHeierJSCiullaTPrimary endpoint results of a phase II study of vascular endothelial growth factor trap-eye in wet age-related macular degenerationOphthalmology20111181089109721640257
   PubMed Web of Science ®Google Scholar
• HeierJSBoyerDNguyenQDThe 1-year results of CLEAR-IT 2, a phase 2 study of vascular endothelial growth factor trap-eye dosed as-needed after 12-week fixed dosingOphthalmology20111181098110621640258
   PubMed Web of Science ®Google Scholar
• Two Year Results of Phase 3 Studies with EYLEA™ (aflibercept) Injection in wet AMD Show Sustained Improvement in Visual Acuity http://investor.regeneron.com/releasedetail.cfm?ReleaseID=629800Accessed 4/13/2012
   Google Scholar
• GaudreaultJFeiDRusitJSubocPShiuVPreclinical pharmacokinetics of ranibizumab (rhuFabV2) after a single intravitreal administrationInvest Ophthalmol Vis Sci200546272673315671306
   PubMed Web of Science ®Google Scholar
• A Prescription for Savings: Reducing Drug Costs to Medicare http://aging.senate.gov/events/hr236pr.pdfAccessed 4/13/2012
   Google Scholar
• StewartMWRosenfeldPJPenhaFMPharmacokinetic rationale for dosing every 2 weeks versus 4 weeks with intravitreal ranibizumab, bevacizumab, and aflibercept (vascular endothelial growth factor trap-eye)Retina2012323343457
   Web of Science ®Google Scholar